ANTX

AN2 Therapeutics, Inc.

Healthcare · Biotechnology

$280.94 sample

+2.53 (+0.91%) 1D

Market cap

$908.8B

Price as of

2026-10-23

Latest filing

8-K · 2026-10-08

Alerts

8

Price$280.94 +5.13% 3M daily closessample

290.16266.14

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 15INSInsider sell: Director
Oct 08SEC10-Q filed
Oct 01SEC8-K filed: material event
Sep 23INSInsider sell: Director
Sep 16INSInsider sell: General Counsel
Sep 10INSInsider sell: Director
Sep 07SECForm 144 filed
Aug 28INSInsider sell: Chief Financial Officer

Sign up to see the real ANTX record →

Company facts

SEC EDGAR registration

Name: AN2 Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -49sample, -100 to +100
Reporting currency: USD

Who is positioning in ANTX

sample

Insiders: 26 insider transactions over 90 days, net selling, $460.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 11 funds hold $20.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$47.9B +20.6% y/y

Q4 2024Q3 2026

Inventory$27.7B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$21.6B +10.5% y/y

Q4 2024Q3 2026

Total debt$55.5B +7.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $313.6B +3.6% 3M
Sample peer B: $532.5B +14.2% 3M
Sample peer C: $478.1B +5.3% 3M
Sample peer D: $674.8B -2.2% 3M
Sample peer E: $880.9B -5.4% 3M